Delivery Order SPE2DB22D1202-SPE2DB25FUTB8

Award Date 2/18/25
Potential Completion Date 3/11/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,129.80, is a Firm Fixed Price Delivery Order for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 period, including an emergency use authorization (EUA) 0.9 ML product. The contract has an ultimate completion date of March 6, 2025 and was awarded on February 12, 2025. This...
This federal contract award is a delivery order valued at $1,129.80 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 0.9ML doses of the Pfizer COVID-19 vaccine for the 2024-2025 period, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 3, 2025 and is a firm fixed-price arrangement. This delivery order is part...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccine doses from 2024-2025 under the Emergency Use Authorization (EUA). The contract has a ceiling value of $3,389.40 and a completion date of February 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period. The award, valued at $1,092.06, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award is a delivery order worth $1,642.75 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the provision of Pfizer COVID-19 vaccines between 2024-2025, with an ultimate completion date of November 7, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a $4,866.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Pfizer COVID-19 vaccines with a delivery period from 2024 to 2025. The contract has an ultimate completion date of January 23, 2025 and was awarded on December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccines and related medical products. The $11,357.70 firm fixed-price contract has an ultimate completion date of October 10, 2024. The award is likely part of a larger indefinite delivery contract the company holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Pfizer COVID-19 vaccines in the 2024-2025 timeframe. The contract has a ceiling value of $1,129.80 and is for 0.9 ml dosages under the Emergency Use Authorization (EUA). The contract is for a firm fixed price and does not have any set-aside designations. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award, valued at $3,407.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, with a period of performance through November 18, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designations, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,778.54 Firm Fixed Price Delivery Order is for the supply of Pfizer COVID-19 vaccine doses (0.9 ML) for the years 2024-2025 under the Food and Drug Administration's Emergency Use Authorization (EUA). The contract has an ultimate completion date of September 20, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUTB8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pfizer COVID-19 vaccines for the 2024-2025 period under an Emergency Use Authorization (EUA). The contract has a ceiling value of $1,622.03 and an ultimate completion date of March 11, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 5/20/25, 2:19 PM